RecruitingNCT07368647

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

Sponsor

Rachel A. Moses

Enrollment

100 participants

Start Date

Apr 4, 2022

Study Type

OBSERVATIONAL

Conditions

Radiation Cystitis Urinary Tract Infection (Diagnosis)

Summary

Collection of urine, blood, and tissue samples from patients undergoing hyperbaric oxygen therapy

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Hyperbaric Oxygen Therapy for people with radiation cystitis and urinary tract infection (diagnosis). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHyperbaric Oxygen Therapy

Hyperbaric Oxygen Therapy (HBOT) is the only non-invasive treatment modality for Radiation Cystitis, performed by placing patients in chambers and introducing them to steep oxygen gradients (100% oxygen at a pressure of 240-250kPa) for 80 to 90 minutes per day in up to 60 consecutive sessions.